Atorvastatin improved scopolamine-induced impairment in memory acquisition in mice: Involvement of nitric oxide

Brain Research

Volumn 1386, Issue , 2011, Pages 89-99

  Javadi Paydar, Mehrak ^a,b   Rayatnia, Farhoud ^a,c   Fakhraei, Nahid ^c   Zakeri, Marjan ^a,b   Mirazi, Naser ^d   Norouzi, Abbas ^b   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BU ALI SINA UNIVERSITY   (Iran)

Author keywords

Acquisition; Atorvastatin; Mice; Nitric oxide; Spatial recognition memory

Indexed keywords

AMINOGUANIDINE; ARGININE; ATORVASTATIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEAR; LATENT PERIOD; MEMORY DISORDER; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RECOGNITION; SHORT TERM MEMORY;

ANIMALS; ARGININE; CHOLINERGIC ANTAGONISTS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GUANIDINES; HEPTANOIC ACIDS; LEARNING DISORDERS; MEMORY; MEMORY DISORDERS; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PYRROLES; SCOPOLAMINE HYDROBROMIDE;

MUS;

EID: 79953848675     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.02.057     Document Type: Article

References (65)

1. Allami, N., Javadi-Paydar, M., Rayatnia, F., Sehhat, K., Rahimian, R., Norouzi, A., Dehpour, A.R., 2011. Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine- inducedmemory impairment in mice. Eur. J. Pharmacol. 650, 240-248.
2. Austen, B., Christodoulou, G., Terry, J.E., 2002. Relation between cholesterol levels, statins and Alzheimer's disease in the human population. J. Nutr. Health Aging 6, 377-382. (Pubitemid 36024781)
3. Bannerman, D.M., Chapman, P.F., Kelly, P.A., Butcher, S.P., Morris, R.G., 1994. Inhibition of nitric oxide synthase does not impair spatial learning. J. Neurosci. 14, 7404-7414. (Pubitemid 24379750)
4. Blanco-Colio, L.M., Tuñón, J., Martín-Ventura, J.L., Egido, J., 2003. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int. 63, 12-13.
5. Blokland, A., 1995. Acetylcholine: a neurotransmitter for learning and memory? Brain Res. Rev. 21, 285-300.
6. Bohme, G.A., Bon, C., Lemaire, M., Reibaud, M., Piot, O., Stutzmann, J.M., Doble, A., Blanchard, J.C., 1993. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc. Natl Acad. Sci. USA 90, 9191-9194.
7. Bredt, D.S., Snyder, S.H., 1992. Nitric oxide, a novel neuronal messenger. Neuron 8, 3-11.
8. Chapman, P.F., Atkins, C.M., Allen, M.T., Haley, J.E., Steinmetz, J.E., 1992. Inhibition of nitric oxide synthesis impairs two different forms of learning. NeuroReport 3, 567-570.
9. Chen, D., Endres, R., Maa, Y.F., Kensil, C.R., Whitaker-Dowling, P., Trichel, A., Youngner, J.S., Payne, L.G., 2003. Epidermal powder immunization of mice and monkeys with an influenza vaccine. Vaccine 21, 2830-2836. (Pubitemid 36703194)
10. Das, U.N., 2002. Nitric oxide as the mediator of the antiosteoporotic actions of estrogen, statins, and essential fatty acids. Exp. Biol. Med. Maywood 227, 88-93.
11. Dellu, F., Contarina, A., Simon, H., Koob, G.F., Gold, L.H., 2000. Genetic differences in response to novelty and spatial memory using two-trial recognition task in mice. Neurobiol. Learn. Mem. 73, 31-48.
12. Dellu, F., Mayo, W., Cherkaoui, J., Le Moal, M., Simon, H., 1992. A two-trial memory task with automated recording: study in young and aged rats. Brain Res. 588, 132-139.
13. Devan, B.D., Pistell, P.J., Daffin Jr., L.W., Nelson, C.M., Duffy, K.B., Bowker, J.L., Bharati, I.S., Sierra-Mercado, D., Spangler, E.L., Ingram, D.K., 2007. Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nomega-nitro-L-arginine methyl ester. Eur. J. Pharmacol. 563, 134-140.
14. Endres, M., Laufs, U., 1998. HMG-CoA reductase inhibitor and risk of stroke. Nervenarzt 69, 717-721. (Pubitemid 28384782)
15. Holscher, C., Rose, S.P., 1993. Inhibiting synthesis of the putative retrograde messenger nitric oxide results in amnesia in a passive avoidance task in the chick. Brain Res. 619, 189-194. (Pubitemid 23214321)
16. Jick, H., Zornberg, G.L., Jick, S.S., Seshadri, S., Drachman, D.A., 2000. Statins and the risk of dementia. Lancet 356, 1627-1631.
17. Kandel, E.R., 2001. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030-1038. (Pubitemid 33041851)
18. Kirsch, C., Eckert, G.P., Koudinov, A.R., Müller, W.E., 2003. Brain cholesterol, statins andAlzheimer's disease. Pharmacopsychiatry 36, S113-S119. (Pubitemid 37346641)
19. Kopelman, M.D., Corn, T.H., 1988. Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome. Brain 111, 1079-1110.
20. Kopt, S.R., Benton, R.S., Kalfin, R., Giovannini, M.G., Pepeu, G., 2001. NO synthesis inhibition decreases cortical ACh release and impairs retention of a conditioned response. Brain Res. 849, 141-144. (Pubitemid 32197607)
21. Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D.J., Sessa, W.C., Walsh, K., 2000. The HMG-CoA reductase inhibitor, simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat. Med. 6, 1004-1010.
22. Kurosaki, R., Muramatsu, Y., Kato, H., Araki, T., 2004. Protective effect of pitavastatin a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor on ischemia-induced neuronal damage. Neurol. Res. 26, 684-691.
23. Laufs, U., Gertz, K., Dirnagl, U., Böhm, M., Nickenig, G., Endres, M., 2002. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res. 942, 23-30. (Pubitemid 34597065)
24. Laufs, U., Gert, K., Huang, P., Nickenig, G., Böhm, M., Dirnagl, U., Endres, M., 2000. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31, 2442-2449.
25. Li, L., Cao, D., Kim, H., Lester, R., Fukuchi, K., 2006. Simvastatin enhances learning and memory independent of amyloid load in mice. Ann. Neurol. 60, 729-739.
26. Liao, J.K., Laufs, U., 2005. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45, 89-118.
27. Liu, Z.W., Zhang, T., Yang, Z., 2007. Involvement of nitric oxide in spatial memory deficits in status epilepticus rats. Neurochem. Res. 32, 1875-1883.
28. Lu, D., Mahmood, A., Qu, C., Goussev, A., Lu, M., Chopp, M., 2004. Atorvastatin reduction of intracranial hematoma volume in rats subjected to controlled cortical impact. J. Neurosurg. 101, 822-825. (Pubitemid 39430976)
29. Lu, D., Qu, C., Goussev, A., Jiang, H., Lu, C., Schallert, T., Mahmood, A., Chen, J., Li, Y., Chopp, M., 2007. Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region and improve spatial learning in rat after traumatic brain injury. J. Neurotrauma 24, 1132-1146. (Pubitemid 47106287)
30. Malenka, R.C., Nicoll, R.A., 1999. Long-term potentiation - a decade of progress? Science 285, 1870-1874.
31. Mans, R.A., Chowdhury, N., Cao, D., McMahon, L.L., Li, L., 2010. Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice. Neuroscience 166, 435-444.
32. Martin, S.J., Grimwood, P.D., Morris, R.G., 2000. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 23, 649-711.
33. McGuinness, B., Passmore, P., 2010. Can statins prevent or help treat Alzheimer's disease? J. Alzheimers Dis. 20, 925-933.
34. McGuinness, B., Craig, D., Bullock, R., Passmore, P., 2009. Statins for the prevention of dementia. Cochrane Database Syst. Rev. 15 (2), CD003160.
35. Meyer, R.C., Spangler, E.L., Kametani, H., Ingram, D.K., 1998. Age-associated memory impairment: assessing the role of nitric oxide. Ann. N. Y. Acad. Sci. 854, 307-317.
36. Moncada, S., Palmer, R.M., Higgs, E.A., 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
37. Müller, U., 2000. Prolonged activation of cAMP-dependent protein kinase during conditioning induces long-term memory in honeybees. Neuron 27, 159-168.
38. Newhouse, P.A., 1990. Cholinergic drug studies in dementia and depression. Adv. Exp. Med. Biol. 282, 65-76.
39. Noda, Y., Yamada, K., Nabeshima, T., 1997. Role of nitric oxide in the effect of aging on spatial memory in rats. Behav. Brain Res. 83, 153-158.
40. Parle, M., Singh, N., 2007. Reversal of memory deficits by atorvastatin and simvastatin in rats. Yakugaku Zasshi 127, 1125-1137. (Pubitemid 47035644)
41. Prickaerts, J., Sik, A., van Staveren, W.C., Koopmans, G., Steinbusch, H.W., van der Staay, F.J., de Vente, J., Blokland, A., 2004. Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neuroch. Int. 45, 915-928.
42. Qu, C., Lu, D., Goussev, A., Schallert, T., Mahmood, A., Chopp, M., 2005. Effect of atorvastatin on spatial memory, neuronal survival, and vascular density in female rats after traumatic brain injury. J. Neurosurg. 103, 695-701. (Pubitemid 43193877)
43. Reddy, P.L., Rajasekaran, K., Paul, V., 2002. Evidence for an involvement of nitric oxide in memory of shock avoidance task in rats. Indian J. Physiol. Pharmacol. 46, 119-122.
44. Reiss, A.B., Wirkowski, E., 2007. Role of HMG-CoA reductase inhibitors in neurological disorders: progress to date. Drugs 67, 2111-2120. (Pubitemid 47557089)
45. Roozendaal, B., McGaugh, J.L., 1996. Amygdaloid nuclei lesions differentially affect glucocorticoid-induced memory enhancement in an inhibitory avoidance task. Neurobiol. Learn. Mem. 65, 1-8.
46. Roozendaal, B., McGaugh, J.L., 1997. Basolateral amygdala lesions block the memory-enhancing effect of glucocorticoid administration in the dorsal hippocampus of rats. Eur. J. Neurosci. 9, 76-83.
47. Schulz, R., 2005. Pleiotropic effects of statins: acutely good, but chronically bad? J. Am. Coll. Cardiol. 45, 1292-1294.
48. Sparks, D.L., Sabbagh, M.N., Connor, D.J., Lopez, J., Launer, L.J., Browne, P., Wasser, D., Johnson-Traver, S., Lochhead, J., Ziolwolski, C., 2005. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch. Neurol. 62, 753-757.
49. Sparks, D.L., Sabbagh, M., Connor, D., Soares, H., Lopez, J., Stankovic, G., Johnson-Traver, S., Ziolkowski, C., Browne, P., 2006. Statin therapy in Alzheimer's disease. Acta Neurol. Scand. Suppl. 185, 78-86.
50. Stevens, R., 1981. Scopolamine impairs spatial maze performance in rats. Physiol. Behav. 27, 385-386.
51. Susswein, A.J., Katzoff, A., Miller, N., Hurwitz, I., 2004. Nitric oxide and memory. Neuroscientist 10, 153-162. (Pubitemid 38372876)
52. Takemoto, M., Liao, J.K., 2001. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21, 1712-1719.
53. Tan, S.E., 2007. Roles of hippocampal nitric oxide and calcium/calmodulin-dependent protein kinase II in inhibitory avoidance learning in rats. Behav. Pharmacol. 18, 29-38.
54. Thomas, T., 2000. Monoamine oxidase-B inhibitors in the treatment of Alzheimer's disease. Neurobiol. Aging 21, 343-348. (Pubitemid 30387093)
55. Tschäpe, J.A., Hartmann, T., 2006. Therapeutic perspectives in Alzheimer's disease. Recent Pat. CNS Drug Discov. 1, 119-127.
56. Udayabanu, M., Kumaran, D., Nair, R.U., Srinivas, P., Bhagat, N., Aneja, R., Katyal, A., 2008. Nitric oxide associated with iNOS expression inhibits acetylcholinesterase activity and induces memory impairment during acute hypobaric hypoxia. Brain Res. 1230, 138-149.
57. Vaughan, C.J., 2003. Prevention of stroke and dementia with statins: effects beyond lipid lowering. Am. J. Cardiol. 91, 23B-29B.
58. Vaughan, C.J., Delanty, N., 1999. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 30, 1969-1973. (Pubitemid 29411843)
59. Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T., Delon, M.R., 1982. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215, 1237-1239. (Pubitemid 12106486)
60. Wolfrum, S., Dendorfer, A., Schutt, M., Weidtmann, B., Heep, A., Tempel, K., Klein, H.H., Dominiak, P., Richardt, G., 2004. Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway. J. Cardiovasc. Pharmacol. 44, 348-355.
61. Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G.G., Siegel, G., 2000. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57, 1439-1443.
62. Yamada, K., Hiramatsu, M., Noda, Y., Mamiya, T., Murai, M., Kameyama, T., Komori, Y., Nikai, T., Sugihara, H., Nabeshima, T., 1996. Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice. Neuroscience 74, 365-374. (Pubitemid 26274208)
63. Yamada, K., Noda, Y., Nakayama, S., Komori, Y., Sugihara, H., Hasegawa, T., Nabeshima, T., 1995. Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br. J. Pharmacol. 115, 852-858.
64. Zandi, P.P., Sparks, D.L., Khachaturian, A.S., Tschanz, J., Norton, M., Steinberg, M., Welsh-Bohmer, K.A., Breitner, J.C., 2005. Do statins reduce risk of incident dementia and Alzheimer disease? Arch. Gen. Psychiatry 62, 217-224.
65. Zhou, B., Teramukai, S., Fukushima, M., 2007. Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis. Dement. Geriatr. Cogn. Disord. 23, 194-201.